Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers

doi:10.1001/jamaoncol.2018.0211

Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers

Computer Science

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1059-1065
Number of pages	7
Journal	JAMA Oncology
Volume	4
Issue number	8
DOIs	https://doi.org/10.1001/jamaoncol.2018.0211
Publication status	Published - Aug 2018

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2018.0211

Cite this

@article{d4dd181293d24a3b9a4ef60e12cf62c9,

title = "Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers",

author = "Daniel Rayson",

year = "2018",

month = aug,

doi = "10.1001/jamaoncol.2018.0211",

language = "English",

volume = "4",

pages = "1059--1065",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers

AU - Rayson, Daniel

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85051419051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051419051&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.0211

DO - 10.1001/jamaoncol.2018.0211

M3 - Article

C2 - 29710224

AN - SCOPUS:85051419051

SN - 2374-2437

VL - 4

SP - 1059

EP - 1065

JO - JAMA Oncology

JF - JAMA Oncology

IS - 8

ER -

Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this